Beximco Pharmaceuticals (DHA:BXPHARMA) Operating Cash Flow per Share : BDT8.75 (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Operating Cash Flow per Share?

Beximco Pharmaceuticals's operating cash flow per share for the three months ended in Mar. 2024 was BDT4.78. Beximco Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was BDT8.75.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Beximco Pharmaceuticals was 48.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 3.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Beximco Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

DHA:BXPHARMA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -30.2 Med: 20.8 Max: 51.7
Current: 3.2

During the past 13 years, Beximco Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.70% per year. The lowest was -30.20% per year. And the median was 20.80% per year.

DHA:BXPHARMA's 3-Year OCF Growth Rate is ranked worse than
55.27% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.4 vs DHA:BXPHARMA: 3.20

Beximco Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Beximco Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Operating Cash Flow per Share Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

6.64

12.42

13.50

11.69

13.64

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															3.79	4.34	3.98	-	4.78

Competitive Comparison of Beximco Pharmaceuticals's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beximco Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Beximco Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Beximco Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	6084.787	/	446.112
	=	13.64

Beximco Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	2131.026	/	446.112
	=	4.78

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT8.75

Beximco Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines